معرفی
Xiaoyang Cheng is a Research Scientist in the Department of Neurology at Yale School of Medicine, specializing in pain mechanisms and ion channel physiology. Working within the Center for Neuroscience and Regeneration Research, Dr. Cheng collaborates extensively with prominent researchers including Stephen Waxman, Sulayman Dib-Hajj, and Philip Effraim.
Dr. Cheng's research focuses on understanding the molecular mechanisms of pain, particularly through the study of sodium channels (Nav1.7, Nav1.8) and other ion channels involved in sensory neuron function. Their work spans genetic studies of pain disorders, channelopathies, and the development of potential therapeutic targets for chronic pain conditions. Key research areas include TRP channels in ocular pain, sodium channel mutations in small fiber neuropathy, and the effects of natural toxins on pain signaling pathways.
Analysis of Dr. Cheng's publication record reveals a strong focus on translational neuroscience, with research spanning molecular mechanisms, animal models, and human genetic studies. The work demonstrates consistent contributions to understanding how ion channel dysfunction leads to pathological pain states, with particular emphasis on sodium channel variants and their role in inherited pain disorders. Recent publications highlight work on TRPM8 mutations related to ocular pain and Nav1.8's role in chemotherapy-induced neuropathy.
Dr. Cheng maintains active collaborations within the Yale neuroscience community and with international researchers, contributing to the understanding of pain mechanisms and potential therapeutic approaches. The research has implications for developing targeted treatments for chronic pain conditions that currently lack effective therapies.